TFX vs UFPT
TFX: Teleflex provides essential, specialty medical technologies used in critical care and surgical procedures to improve patient outcomes. UFPT: UFP Technologies is a custom-engineered component manufacturer providing specialized solutions primarily for the medical device and healthcare industries.
Side-by-side fundamentals
| Metric | TFX | UFPT | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $124.19 | $286.56 | |
| Market cap | $5.3B | $2.2B | |
| P/E as of 2026-10-08 | n/a | 30.95 | |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | n/a | 1.81 | |
| Net margin FY2025, SEC XBRL | -45.4% | +11.3% | UFPT higher |
| Gross margin FY2025, SEC XBRL | +56.2% | +28.3% | TFX higher |
| Operating margin FY2025, SEC XBRL | +5.9% | +15.3% | UFPT higher |
| ROE FY2025, SEC XBRL | -29.0% | +16.1% | UFPT higher |
| ROA FY2025, SEC XBRL | -13.0% | +10.4% | UFPT higher |
| Debt / equity as of 2026-09-02 | 0.97 | 0.25 | UFPT lower |
| Revenue growth (YoY) as of 2026-09-02 | -14.5% | +7.3% | UFPT higher |
| Revenue CAGR (3y) SEC XBRL | -10.6% | +22.7% | UFPT higher |
| Dividend yield as of 2026-09-02 | +1.1% | n/a | |
| Dividend streak (yrs) SEC XBRL | 18 | 0 | TFX higher |
| Beta as of 2026-09-02 | 0.74 | 1.04 | |
| 1-year return as of 2026-10-08 close | -3.3% | +45.9% | UFPT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.